Monoclonal antibody-targeted polymeric nanoparticles for cancer therapy - future prospects

2014 ◽  
Vol 90 (7) ◽  
pp. 1169-1176 ◽  
Author(s):  
Stephen Goodall ◽  
Martina L. Jones ◽  
Stephen Mahler
Keyword(s):  
Monoclonal Antibody ◽  
Cancer Therapy ◽  
Polymeric Nanoparticles ◽  
Future Prospects

Immunohistochemically detecting target antigens in patient biopsies for tailoring monoclonal antibody based cancer therapy

1999 ◽  
Vol 9 (1) ◽  
pp. 61-65 ◽  
Author(s):  
Nancy L. Smith ◽  
James L. Finley ◽  
Anne E. Wennerberg ◽  
Diane A. Semer ◽  
Kelly P. Kearse
Keyword(s):  
Monoclonal Antibody ◽  
Cancer Therapy

Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy

2012 ◽  
Vol 2 (6) ◽  
pp. 418-436 ◽  
Author(s):  
Athulya Aravind ◽  
Yasuhiko Yoshida ◽  
Toru Maekawa ◽  
D. Sakthi Kumar
Keyword(s):  
Cancer Therapy ◽  
Polymeric Nanoparticles ◽  
Targeted Cancer Therapy

Current Therapies and Future Prospects

2021 ◽  
pp. 306-318
Author(s):  
Muddukrishnaiah K.
Keyword(s):  
Drug Delivery ◽  
Drug Resistance ◽  
Cancer Therapy ◽  
Cancer Diagnosis ◽  
Biomarker Discovery ◽  
Future Prospects ◽  
Cancer Treatments ◽  
Therapeutic Uses ◽  
Current Therapies ◽  
Targeted Drug

Due to drug resistance, lack of cancer cell selectivity, and solubility, conventional cancer treatments lose their therapeutic uses, and as such, new therapeutic agents need to be developed. Nanomaterials and peptides are increasingly being used in the fields of cancer diagnosis, biomarker discovery due to their therapeutic values and novel way of targeting and curing the disease. Synergism among the peptide-conjugated nanoparticles is an exhilarating group of materials, not only sharing the benefits of conventional nanomedicine, but also possessing the unique properties of excellent biocompatibility, biodegradability, versatile sensitivity, specific biological purpose, and synthetic feasibility. These virtues inspired by the scientists and have taken advantage in the peptide-conjugated nano drugs for the accurate delivery of drugs reliably to the site of the lesion. This chapter offers a summary of emerging technologies that have recently been developed in the broad field of peptide-conjugated nanoparticles and offers guidance for targeted drug delivery and cancer therapy.

Polymeric Nanoparticles Integrated from Discrete Organoplatinum(II) Metallacycle by Stepwise Post-assembly Polymerization for Synergistic Cancer Therapy

2020 ◽  
Vol 32 (11) ◽  
pp. 4564-4573 ◽  
Author(s):  
Jiong Zhou ◽  
Guocan Yu ◽  
Jie Yang ◽  
Bingbing Shi ◽  
Boyong Ye ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Polymeric Nanoparticles
Sign in / Sign up

Export Citation Format

Share Document